SCHEMBL15906236

SCHEMBL15906236

CC(C)(CN1CCCC1)C(=O)N[C@H]1CC[C@H](C)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
EPHX1 P07099 1/20 0.44
CSNK2A2 P19784 1/20 0.40
CSNK2A1 P68400 1/20 0.40
MAPK1 P28482 2/20 0.40
FPR3 P25089 1/20 0.39
FPR2 P25090 1/20 0.39
SIGMAR1 Q99720 1/20 0.38
SSTR4 P31391 5/20 0.38
ADRA2A P08913 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
SSTR1 P30872 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15906233 0.88 EPHX1 (0.38) ALDH1A1EPHX1MAPK1SIGMAR1SSTR4
SCHEMBL15906207 0.87 CNR1 (0.42) ALDH1A1EPHX1SSTR4SMN1; SMN2NPC1
SCHEMBL14652181 0.84 ALDH1A1 (0.41) ALDH1A1CSNK2A2CSNK2A1MAPK1SIGMAR1
SCHEMBL15906245 0.77 EPHX1 (0.47) ALDH1A1EPHX1MAPK1SSTR4ADRA2A
SCHEMBL14655013 0.76 EPHX1 (0.46) ALDH1A1EPHX1MAPK1SSTR4ADRA2A
SCHEMBL15906238 0.76 EPHX1 (0.46) ALDH1A1EPHX1MAPK1SSTR4ADRA2A
SCHEMBL15906201 0.75 EPHX1 (0.52) ALDH1A1EPHX1MAPK1SIGMAR1ADRA2A
SCHEMBL803835 0.74 EPHX1 (0.44) ALDH1A1EPHX1MAPK1SSTR4ADRA2A
SCHEMBL14654940 0.74 EPHX1 (0.44) ALDH1A1EPHX1MAPK1SSTR4ADRA2A
SCHEMBL14174994 0.74 SIGMAR1 (0.59) ALDH1A1EPHX1MAPK1SIGMAR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791257-B2 Substituted pyrrolotriazines as protein kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-07-29 US disclosed